Polen Capital's position in Medtronic Plc is currently worth $65.3 Million. That's 0.18% of their equity portfolio (32nd largest holding). The first Medtronic Plc trade was made in Q4 2017. Since then Polen Capital bought shares nineteen more times and sold shares on nine occasions. The investor's estimated purchase price is $78.1 Million, resulting in a loss of 16%.
Polen Capital, an investment management company, released its “Polen International Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same c...
… com reports. The institutional investor bought 72,030 shares of … period. Capital Research Global Investors boosted its holdings in shares … Wednesday, Aug...
Investors are worried that the stock market’s first-half performance in 2023 is reversing. It’s unclear what part of the business cycle we are currently in. ...
… Exchange Commission. The institutional investor bought 157,390 shares … number of other institutional investors also recently modified their … funds and ot...